XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.2
THE COMPANY AND BASIS OF PRESENTATION - Narrative (Details)
3 Months Ended 6 Months Ended
Apr. 23, 2024
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]            
Reverse stock split 0.05          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Accumulated deficit   $ (660,456,000)   $ (660,456,000)   $ (611,258,000)
Reversal due to settlement of indirect tax liabilities   3,935,000 $ 0 9,445,000 $ 0  
Indirect tax amounts, decrease resulting from settlement with taxing authorities   500,000   3,400,000    
Indirect tax amounts, income tax penalties and interest accrued, decrease resulting from settlement with taxing authorities   4,200,000   5,200,000    
Total revenues | Rezafungin            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Liabilities related to discontinued operations   0   0   0
Assets related to discontinued operations   $ 0   $ 0   $ 0